financetom
Business
financetom
/
Business
/
What's Going On With Colombier Shares On Tuesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Colombier Shares On Tuesday?
Jul 15, 2025 10:12 AM

Colombier Acquisition Corp. II ( CLBR ) stock traded lower Tuesday as investors weighed potential risks tied to the company’s imminent merger with GrabAGun, an online retailer of firearms and ammunition.

On Friday, Colombier II announced it had received minimal redemption requests from shareholders ahead of the deal’s expected closing, signaling strong investor support.

The company anticipates delivering more than $179.1 million in gross proceeds to GrabAGun Digital Holdings upon completion of the transaction, expected to close today, July 15, 2025.

Also Read: Colombier Acquisition Corp. II Shares Surge As GrabAGun SPAC Deal Advances With New Filing

Nearly all of Colombier’s trust account will be transferred to the merged entity, and the company confirmed it will not permit reversal of submitted redemption requests.

An extraordinary general meeting was scheduled for July 15 for shareholders to vote on the proposals tied to the transaction.

The merger agreement was originally signed on January 6, 2025, and pending NYSE approval, the combined company is expected to trade under the ticker symbols “PEW” and “PEWW.”

Despite minimal redemptions, the stock may be under pressure due to concerns around GrabAGun’s entry into public markets as a politically sensitive and highly regulated business and uncertainty over its post-merger financial performance. Some investors may also be engaging in profit-taking or “sell-the-news” behavior following confirmation of the merger.

Price Action: CLBR shares are trading lower by 7.13% at $15.75 at Tuesday’s last check.

Read Next:

Fastenal Analysts Boost Their Forecasts After Upbeat Earnings

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved